These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20337509)

  • 1. Anxiety and mood disorders and cannabis use.
    Cheung JT; Mann RE; Ialomiteanu A; Stoduto G; Chan V; Ala-Leppilampi K; Rehm J
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):118-22. PubMed ID: 20337509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use and mental health-related quality of life among individuals with anxiety disorders.
    Lev-Ran S; Le Foll B; McKenzie K; Rehm J
    J Anxiety Disord; 2012 Dec; 26(8):799-810. PubMed ID: 23023160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a U-shaped relationship exist between alcohol use and DSM-III-R mood and anxiety disorders?
    Sareen J; McWilliams L; Cox B; Stein MB
    J Affect Disord; 2004 Oct; 82(1):113-8. PubMed ID: 15465583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of mood and anxiety disorders in Australian women.
    Williams L; Jacka F; Pasco J; Henry M; Dodd S; Nicholson G; Kotowicz M; Berk M
    Australas Psychiatry; 2010 Jun; 18(3):250-5. PubMed ID: 20482429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of administrative data for the surveillance of mood and anxiety disorders.
    Kisely S; Lin E; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1118-25. PubMed ID: 20001410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.
    Grant BF; Hasin DS; Stinson FS; Dawson DA; Patricia Chou S; June Ruan W; Huang B
    J Psychiatr Res; 2005 Jan; 39(1):1-9. PubMed ID: 15504418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental-physical comorbidity in an ethnically diverse population.
    Scott K; McGee MA; Schaaf D; Baxter J
    Soc Sci Med; 2008 Mar; 66(5):1165-73. PubMed ID: 18155819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study.
    Huang KL; Su TP; Chen TJ; Chou YH; Bai YM
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):401-9. PubMed ID: 19566773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey.
    Levinson D; Zilber N; Lerner Y; Grinshpoon A; Levav I
    Isr J Psychiatry Relat Sci; 2007; 44(2):94-103. PubMed ID: 18080646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering comorbidity in social phobia.
    Chartier MJ; Walker JR; Stein MB
    Soc Psychiatry Psychiatr Epidemiol; 2003 Dec; 38(12):728-34. PubMed ID: 14689178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age-period-cohort analysis of cannabis use prevalence and frequency in Germany, 1990-2009.
    Piontek D; Kraus L; Pabst A; Legleye S
    J Epidemiol Community Health; 2012 Oct; 66(10):908-13. PubMed ID: 22016398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
    van Laar M; van Dorsselaer S; Monshouwer K; de Graaf R
    Addiction; 2007 Aug; 102(8):1251-60. PubMed ID: 17624975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.